Pravin Dugel (OCUL) reports bona fide gifts of 100,184 OCULAR THERAPEUTIX shares

Rhea-AI Filing Summary

OCULAR THERAPEUTIX, INC director and officer Pravin Dugel reported bona fide gifts of Common Stock. On June 16, 2026, he reported two gift transactions totaling 100,184 shares, including 50,092 shares transferred to his spouse for no consideration.

After these transactions, Dugel reports 2,547,078 shares held directly, 694,811 shares held indirectly through the Pravin Dugel 2024 Irrevocable Trust, and 50,092 shares held indirectly by his spouse.

Insights

Insider trading analyst

Form 4 shows non-market gifts of OCUL shares with substantial holdings retained.

Pravin Dugel reported two bona fide gift transactions totaling 100,184 shares of OCULAR THERAPEUTIX common stock on June 16, 2026. These are non-market transfers at a reported price of $0.0000 per share, so they do not reflect open-market selling.

Following the gifts, he still reports direct ownership of 2,547,078 shares, plus indirect interests of 694,811 shares via the 2024 Irrevocable Trust and 50,092 shares via his spouse. Given the non-cash nature of the gifts and the large remaining position, this filing is generally a routine disclosure rather than a thesis-changing event.

Insider Trade Summary

100,184 shares gifted

Mixed 3 txns

Insider Dugel Pravin

Role See Remarks

Type	Security	Shares	Price	Value
Gift	Common Stock	50,092	$0.00	--
Gift	Common Stock	50,092	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,547,078 shares (Direct, null); Common Stock — 50,092 shares (Indirect, By spouse)

Footnotes (1)

1. [object Object]

Key Figures

Total gifted shares: 100,184 shares Gift to spouse: 50,092 shares Direct holdings after transactions: 2,547,078 shares +3 more

6 metrics

Total gifted shares 100,184 shares Bona fide gifts on June 16, 2026

Gift to spouse 50,092 shares Transferred for no consideration on June 16, 2026

Direct holdings after transactions 2,547,078 shares Common Stock held directly after gifts

Trust indirect holdings 694,811 shares Held by Pravin Dugel 2024 Irrevocable Trust

Spouse indirect holdings 50,092 shares Common Stock held indirectly by spouse after transfer

Gift transaction price $0.0000 per share Reported price for both G-code transactions

Key Terms

bona fide gift, Form 4, indirect ownership, Common Stock, +1 more

5 terms

bona fide gift financial

"transaction_code_description": "Bona fide gift""

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

indirect ownership financial

""ownership_type": "indirect", "ownership_code": "I""

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Irrevocable Trust financial

"By Pravin Dugel 2024 Irrevocable Trust"

An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dugel Pravin

(Last) (First) (Middle)

C/O OCULAR THERAPEUTIX, INC.

14 CROSBY DRIVE, 3RD FLOOR

(Street)

BEDFORD MASSACHUSETTS 01730

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OCULAR THERAPEUTIX, INC [ OCUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		G(1)		50,092	D	$0	2,547,078	D
Common Stock	06/16/2026		G(1)		50,092	A	$0	50,092	I	By spouse
Common Stock								694,811	I	By Pravin Dugel 2024 Irrevocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On June 16, 2026, the reporting person transferred 50,092 shares to his spouse for no consideration.

Remarks:

Executive Chairman, President and CEO

	/s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Pravin Dugel report in OCUL shares?

Pravin Dugel reported bona fide gifts totaling 100,184 shares of OCULAR THERAPEUTIX common stock. The gifts occurred on June 16, 2026, and were reported at a price of $0.0000 per share, indicating non-market, no-consideration transfers rather than open-market sales.

How many OCUL shares did Pravin Dugel transfer to his spouse?

He transferred 50,092 OCULAR THERAPEUTIX shares to his spouse for no consideration. This transfer is identified as a bona fide gift and is reported at a price of $0.0000 per share, reflecting a non-cash, non-market family-related transaction rather than a sale into the public market.

What are Pravin Dugel’s direct OCUL shareholdings after the reported gifts?

After the reported gift transactions, Pravin Dugel holds 2,547,078 OCULAR THERAPEUTIX common shares directly. This figure represents his remaining direct ownership position following the bona fide gifts disclosed in the Form 4 dated June 16, 2026, and shows he retains a substantial stake.

What indirect OCUL holdings does Pravin Dugel report after these transactions?

He reports 694,811 OCULAR THERAPEUTIX shares held indirectly through the Pravin Dugel 2024 Irrevocable Trust and 50,092 shares held indirectly by his spouse. These indirect interests are disclosed separately from his direct holdings, clarifying the structure of his overall ownership.

Do the reported OCUL transactions involve open-market buying or selling?

No, the transactions are coded as bona fide gifts, not open-market trades. The reported price is $0.0000 per share, indicating non-cash, non-market transfers. As a result, they provide limited insight into Dugel’s view of OCULAR THERAPEUTIX’s current market valuation.

How many total OCUL shares were gifted according to this Form 4?

The Form 4 shows bona fide gifts totaling 100,184 OCULAR THERAPEUTIX common shares. This total comes from two reported G‑code transactions of 50,092 shares each, including a specifically noted transfer of 50,092 shares to Dugel’s spouse for no consideration.